Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	9.08	24.16	22.14
Graham Fair Price	9.21	6211.50	5687.63
PEG	320.15	0.90	0.21
Price/Book	-15.20	0.60	0.71
Price/Cash Flow	-53.96	-12.29	26.69
Prices/Earnings	-27.23	16.03	22.03
Price/Sales	-11.44	1.96	2.21
Price/FCF	-53.96	-12.29	26.69
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	1.10	0.45	0.44
Operating Margin	-26.85	0.04	0.05
ROA	17.77	< 0.005	< 0.005
ROE	< 0.005	< 0.005	16.54
ROIC	0.01	< 0.005	-34.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.19	-0.30	-36.89
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	5.14	-0.29	-94.33
EPS QOQ	1.03	0.18	-82.68
FCF QOQ	1.74	-2.86	64.53
Revenue QOQ	0.41	-0.03	-92.38
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	95.90	103.85	8.29
Days Sales Outstanding (DSO)	62.47	67.60	8.21
Inventory Turnover	0.94	0.87	-7.66
Debt/Capitalization	0.06	0.07	21.75
Quick Ratio	1.58	1.59	0.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13337.43	14767.30	10.72
Cash	2758.74	2239.13	-18.84
Capex	-167.22	349.38	108.93
Free Cash Flow	355.96	-663.32	86.34
Revenue	4289.13	4154.79	-3.13
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.33	2.35	0.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.51	-0.21	91.64
Naive Interpretation	Member

06 - Financial Health · Bad

Rating